FunPep Company Limited Logo

FunPep Company Limited

Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.

4881 | T

Overview

Corporate Details

ISIN(s):
JP3802640007
LEI:
Country:
Japan
Address:
茨木市彩都あさぎ七丁目7−15
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

FunPep Company Limited is a clinical-stage biotechnology company that originated as a spin-out from Osaka University. The company specializes in the research and development of therapeutics based on its proprietary functional peptide and antibody-inducing peptide platform technologies. Its core business is creating novel peptide-based pharmaceutical products. FunPep's development pipeline includes candidates for various indications, such as an allergy vaccine and the functional peptide SR-0379 for intractable ulcers, which has advanced to late-stage clinical trials. The company's business scope also extends to the development of functional cosmetics and medical devices, leveraging the diverse applications of its core peptide technology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:30
Report Publication Announcement
確認書
Japanese 8.4 KB
2025-08-14 08:30
Interim Report
半期報告書-第13期(2025/01/01-2025/12/31)
Japanese 278.9 KB
2025-04-01 08:30
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2025-03-28 08:16
Registration Form
確認書
Japanese 8.5 KB
2025-03-28 08:15
Annual Report
有価証券報告書-第12期(2024/01/01-2024/12/31)
Japanese 1.6 MB
2025-03-28 08:15
Governance Information
内部統制報告書-第12期(2024/01/01-2024/12/31)
Japanese 23.6 KB
2025-02-21 07:30
Registration Form
有価証券届出書(組込方式)
Japanese 447.3 KB
2024-08-08 09:01
Report Publication Announcement
確認書
Japanese 8.4 KB
2024-08-08 09:00
Interim Report
半期報告書-第12期(2024/01/01-2024/12/31)
Japanese 283.1 KB
2024-08-08 03:00
Major Shareholding Notification
臨時報告書
Japanese 21.3 KB
2024-07-05 08:05
Registration Form
有価証券届出書(組込方式)
Japanese 391.3 KB
2024-05-13 08:00
Quarterly Report
確認書
Japanese 8.4 KB
2024-05-13 08:00
Quarterly Report
四半期報告書-第12期第1四半期(2024/01/01-2024/03/31)
Japanese 238.2 KB
2024-04-01 08:05
Post-Annual General Meeting Information
臨時報告書
Japanese 27.7 KB
2024-03-28 07:15
Registration Form
確認書
Japanese 8.5 KB

Automate Your Workflow. Get a real-time feed of all FunPep Company Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FunPep Company Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FunPep Company Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan
7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan
9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea
287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece
INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland
INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea
216400
IQVIA HOLDINGS INC. Logo
Global provider of analytics, tech, and clinical research for life sciences and healthcare.
United States of America
IQV
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden
ISOFOL
B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.
South Korea
052770

Talk to a Data Expert

Have a question? We'll get back to you promptly.